2022 FDA approvals
Nat Rev Drug Discov
.
2023 Feb;22(2):83-88.
doi: 10.1038/d41573-023-00001-3.
Author
Asher Mullard
PMID:
36596858
DOI:
10.1038/d41573-023-00001-3
No abstract available
Publication types
News
MeSH terms
Antineoplastic Agents*
Drug Approval
Humans
United States
United States Food and Drug Administration
Substances
Antineoplastic Agents